Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cytosorbents (CTSO) Preferred Dividend Payments (2017)

Cytosorbents filings provide 5 years of Preferred Dividend Payments readings, the most recent being -$671462.0 for Q4 2017.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to -$671462.0 in Q4 2017 year-over-year; TTM through Dec 2018 was -$671462.0, a 0.0% change, with the full-year FY2017 number at -$335731.0, changed N/A from a year prior.
  • Preferred Dividend Payments hit -$671462.0 in Q4 2017 for Cytosorbents, down from $5.5 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $5.5 million in Q4 2014 to a low of -$671462.0 in Q4 2017.
  • Median Preferred Dividend Payments over the past 3 years was $667467.0 (2013), compared with a mean of $1.2 million.
  • Biggest five-year swings in Preferred Dividend Payments: fell 16.61% in 2013 and later surged 723.54% in 2014.
  • Cytosorbents' Preferred Dividend Payments stood at $667467.0 in 2013, then surged by 723.54% to $5.5 million in 2014, then crashed by 112.22% to -$671462.0 in 2017.
  • The last three reported values for Preferred Dividend Payments were -$671462.0 (Q4 2017), $5.5 million (Q4 2014), and $1.3 million (Q3 2014) per Business Quant data.